Common Genetic Mutation Dramatically Increases Dementia Risk in Men
A recent analysis of nearly 12,200 Australians and Americans reveals that about one in 36 men carries two copies of a small change in the HFE gene, a genetic detail that can more than double his odds of developing dementia. While dementia affects around 433,000 Australians and is more prevalent in women, this new genetic insight indicates that older men with this variant face a significantly higher risk of memory loss.
The HFE gene is crucial for regulating the body's iron levels. Its H63D version is surprisingly common, appearing as a single copy in one in three people and as a double copy in approximately one in 36. Unlike the more well-known C282Y variant, H63D doesn't typically lead to liver iron overload. However, laboratory studies show that the mutant HFE can disrupt cellular iron sensors, allowing free iron to trigger damaging chemical reactions.
Genes, Iron, Brains, and Memory
Iron is essential but also highly reactive. When it accumulates within microglia, the brain's immune cells, it triggers oxidative stress and inflammation, processes strongly linked to Alzheimer's disease. Both animal and human data suggest that iron dyshomeostasis fuels reactive oxygen species, damages neurons, and may even initiate ferroptosis, a specialized form of cell death associated with cognitive decline. HFE variants have also been connected to Parkinson's disease and motor neuron disorders, implying that iron mismanagement could be a common pathway across various brain conditions. Studies have demonstrated that abnormal iron levels in specific brain regions are associated with earlier onset and faster progression of these diseases in genetically susceptible individuals.
What the ASPREE Data Revealed
The ASPREE trial, which followed 19,114 healthy seniors for a median of 6.4 years to test low-dose aspirin, generated a wealth of aging data. Genome scans within the ASPREE study showed that men with two copies of the H63D variant had an adjusted hazard ratio of 2.39 for incident dementia, whereas women with the same genotype showed no additional risk.
"Having two copies of the variant more than doubled the risk of dementia in men, but not women," explained Professor John Olynyk of Curtin University Medical School, who co-led the project.
Why Only Men?
The sex-specific impact likely stems from differences in iron metabolism. Menstruation, pregnancy, and lower mid-life ferritin levels provide women with a natural mechanism to release iron, potentially mitigating the variant's effects. Similarly, haemochromatosis complications tend to appear later and milder in females. Brain-imaging studies suggest that women who stop menstruating early accumulate more iron in deep brain regions, hinting that lifelong iron exposure might push male brains towards damage. Sex hormones further complicate this, as estrogen modulates iron metabolism and offers anti-inflammatory benefits that may protect neural circuits.
While HFE analysis is already part of routine work-ups for suspected iron overload, these new findings suggest that broader screening in aging men could identify a hidden dementia risk before symptoms emerge. Identifying carriers is inexpensive, and unlike many predictive markers, this one points to an actionable pathway: iron handling and its associated inflammatory effects.
Practical Steps Today
Although the research team found no clear link between blood ferritin levels and dementia, maintaining iron within the normal range, treating chronic inflammation, staying active, and adopting a plant-biased diet all contribute to brain health. For example, regular physical activity alone can reduce dementia risk by approximately 30 percent, according to World Health Organization estimates. Doctors also emphasize blood pressure control, smoking cessation, and social engagement—interventions that benefit every older adult, regardless of their genetic predisposition.
Current dementia prevention efforts often rely on broad lifestyle advice or age thresholds. However, this variant suggests a need for sex-aware screening policies. If men with two H63D copies truly carry double the risk, early genetic testing could guide them towards more aggressive prevention strategies long before symptoms become apparent.
Men, Dementia, and the Future
Professor Paul Lacaze from Monash University hopes that a deeper understanding of how H63D alters brain pathways will lead to new medicines that can block the harm, even if the gene itself cannot be changed. Future research will involve tracking variant carriers with MRI iron mapping and fluid biomarkers to detect early inflammatory changes, then testing whether diet, phlebotomy, or anti-ferroptotic drugs can help maintain healthy aging.
It's rare for genetics to offer such a common, sex-specific clue, and this finding comes at a crucial time for a generation of men now entering their 70s. The study's findings have been published in the journal Neurology.
0 Comments